.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Cerilliant
Daiichi Sankyo
Citi
Harvard Business School
AstraZeneca
US Army
Accenture
Cantor Fitzgerald
Mallinckrodt

Generated: July 20, 2017

DrugPatentWatch Database Preview

INSULIN NORDISK MIXTARD (PORK) Drug Profile

« Back to Dashboard

What is the patent landscape for Insulin Nordisk Mixtard (pork), and when can generic versions of Insulin Nordisk Mixtard (pork) launch?

Insulin Nordisk Mixtard (pork) is a drug marketed by Novo Nordisk Inc and is included in one NDA.

The generic ingredient in INSULIN NORDISK MIXTARD (PORK) is insulin purified pork; insulin susp isophane purified pork. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin purified pork; insulin susp isophane purified pork profile page.

Summary for Tradename: INSULIN NORDISK MIXTARD (PORK)

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list4,000
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:INSULIN NORDISK MIXTARD (PORK) at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc
INSULIN NORDISK MIXTARD (PORK)
insulin purified pork; insulin susp isophane purified pork
INJECTABLE;INJECTION018195-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Covington
Boehringer Ingelheim
Cerilliant
Moodys
UBS
Cantor Fitzgerald
Julphar
Chubb
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot